294 related articles for article (PubMed ID: 35506449)
1. Crosstalk between NK cells and hepatic stellate cells in liver fibrosis (Review).
Zhang Y; Wu Y; Shen W; Wang B; Yuan X
Mol Med Rep; 2022 Jun; 25(6):. PubMed ID: 35506449
[TBL] [Abstract][Full Text] [Related]
2. The antifibrotic role of natural killer cells in liver fibrosis.
Wei Y; Bingyu W; Lei Y; Xingxing Y
Exp Biol Med (Maywood); 2022 Jul; 247(14):1235-1243. PubMed ID: 35475367
[TBL] [Abstract][Full Text] [Related]
3. Hepatic stellate cell interferes with NK cell regulation of fibrogenesis via curcumin induced senescence of hepatic stellate cell.
Jin H; Jia Y; Yao Z; Huang J; Hao M; Yao S; Lian N; Zhang F; Zhang C; Chen X; Bian M; Shao J; Wu L; Chen A; Zheng S
Cell Signal; 2017 May; 33():79-85. PubMed ID: 28188823
[TBL] [Abstract][Full Text] [Related]
4. Regulatory CD4+ T cells modulate the interaction between NK cells and hepatic stellate cells by acting on either cell type.
Langhans B; Alwan AW; Krämer B; Glässner A; Lutz P; Strassburg CP; Nattermann J; Spengler U
J Hepatol; 2015 Feb; 62(2):398-404. PubMed ID: 25195554
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between hepatic stellate cells and surrounding cells in hepatic fibrosis.
Yang F; Li H; Li Y; Hao Y; Wang C; Jia P; Chen X; Ma S; Xiao Z
Int Immunopharmacol; 2021 Oct; 99():108051. PubMed ID: 34426110
[TBL] [Abstract][Full Text] [Related]
6. γδT Cells Suppress Liver Fibrosis via Strong Cytolysis and Enhanced NK Cell-Mediated Cytotoxicity Against Hepatic Stellate Cells.
Liu M; Hu Y; Yuan Y; Tian Z; Zhang C
Front Immunol; 2019; 10():477. PubMed ID: 30930903
[TBL] [Abstract][Full Text] [Related]
7. Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-β-dependent emperipolesis in HBV cirrhotic patients.
Shi J; Zhao J; Zhang X; Cheng Y; Hu J; Li Y; Zhao X; Shang Q; Sun Y; Tu B; Shi L; Gao B; Wang FS; Zhang Z
Sci Rep; 2017 Mar; 7():44544. PubMed ID: 28291251
[TBL] [Abstract][Full Text] [Related]
8. Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy.
Cai X; Wang J; Wang J; Zhou Q; Yang B; He Q; Weng Q
Pharmacol Res; 2020 May; 155():104720. PubMed ID: 32092405
[TBL] [Abstract][Full Text] [Related]
9. Treatment with 4-methylpyrazole modulated stellate cells and natural killer cells and ameliorated liver fibrosis in mice.
Yi HS; Eun HS; Lee YS; Jung JY; Park SH; Park KG; Choi HS; Suh JM; Jeong WI
PLoS One; 2015; 10(5):e0127946. PubMed ID: 26024318
[TBL] [Abstract][Full Text] [Related]
10. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B.
Wijaya RS; Read SA; Schibeci S; Eslam M; Azardaryany MK; El-Khobar K; van der Poorten D; Lin R; Yuen L; Lam V; George J; Douglas MW; Ahlenstiel G
J Hepatol; 2019 Aug; 71(2):252-264. PubMed ID: 30905683
[TBL] [Abstract][Full Text] [Related]
11. A novel flow cytometry tool for fibrosis scoring through hepatic stellate cell differentiation.
Amer J; Salhab A; Doron S; Morali G; Safadi R
Cytometry A; 2018 Apr; 93(4):427-435. PubMed ID: 29517852
[TBL] [Abstract][Full Text] [Related]
12. Exosomes derived from natural killer cells inhibit hepatic stellate cell activation and liver fibrosis.
Wang L; Wang Y; Quan J
Hum Cell; 2020 Jul; 33(3):582-589. PubMed ID: 32449114
[TBL] [Abstract][Full Text] [Related]
13. Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in mice.
Jeong WI; Park O; Suh YG; Byun JS; Park SY; Choi E; Kim JK; Ko H; Wang H; Miller AM; Gao B
Hepatology; 2011 Apr; 53(4):1342-51. PubMed ID: 21480338
[TBL] [Abstract][Full Text] [Related]
14. Roles and therapeutic targeting of dendritic cells in liver fibrosis.
Wang B; Yang L; Yuan X; Zhang Y
J Drug Target; 2024 Jul; 32(6):647-654. PubMed ID: 38682473
[TBL] [Abstract][Full Text] [Related]
15. EP3 enhances adhesion and cytotoxicity of NK cells toward hepatic stellate cells in a murine liver fibrosis model.
Tao X; Zhang R; Du R; Yu T; Yang H; Li J; Wang Y; Liu Q; Zuo S; Wang X; Lazarus M; Zhou L; Wang B; Yu Y; Shen Y
J Exp Med; 2022 May; 219(5):. PubMed ID: 35420633
[TBL] [Abstract][Full Text] [Related]
16. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.
Zhang CY; Yuan WG; He P; Lei JH; Wang CX
World J Gastroenterol; 2016 Dec; 22(48):10512-10522. PubMed ID: 28082803
[TBL] [Abstract][Full Text] [Related]
17. CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation.
Hintermann E; Bayer M; Pfeilschifter JM; Luster AD; Christen U
J Autoimmun; 2010 Dec; 35(4):424-35. PubMed ID: 20932719
[TBL] [Abstract][Full Text] [Related]
18. Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients.
Glässner A; Eisenhardt M; Kokordelis P; Krämer B; Wolter F; Nischalke HD; Boesecke C; Sauerbruch T; Rockstroh JK; Spengler U; Nattermann J
J Hepatol; 2013 Sep; 59(3):427-33. PubMed ID: 23665286
[TBL] [Abstract][Full Text] [Related]
19. Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice.
Ma PF; Gao CC; Yi J; Zhao JL; Liang SQ; Zhao Y; Ye YC; Bai J; Zheng QJ; Dou KF; Han H; Qin HY
J Hepatol; 2017 Oct; 67(4):770-779. PubMed ID: 28596109
[TBL] [Abstract][Full Text] [Related]
20. Coordinated signaling of activating transcription factor 6α and inositol-requiring enzyme 1α regulates hepatic stellate cell-mediated fibrogenesis in mice.
Xue F; Lu J; Buchl SC; Sun L; Shah VH; Malhi H; Maiers JL
Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G864-G879. PubMed ID: 33728997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
